Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health Clinics to incorporate the company's metabolomic blood testing into Personalised Health Clinics' personalized, clinician-led healthcare services. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
Frequently asked questions
What sector does Nightingale Health Oyj B (HEALTH) operate in?
Nightingale Health Oyj B belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Nightingale Health Oyj B (HEALTH) current stock price?
As of the latest data, Nightingale Health Oyj B stock price is €1.15, with a previous close of €1.18. Nightingale Health Oyj B lost -€0.03 in the last trading session, representing a -2.54% loss.
What is Nightingale Health Oyj B (HEALTH) current market capitalization?
Nightingale Health Oyj B market cap is approximately 46.74 million.
What is Nightingale Health Oyj B (HEALTH) Earnings Per Share (EPS)?
The trailing EPS is -€0.32, and the forward EPS is -€0.21.
Does Nightingale Health Oyj B (HEALTH) pay dividends?
No. Nightingale Health Oyj B does not pay a dividend.
What is Nightingale Health Oyj B (HEALTH) beta (volatility) score?
Nightingale Health Oyj B has a beta of 0.333, indicating lower volatility than the overall market.
